TBHBIO Company Display

For innovation teams exploring formats beyond the capsule, our P40C white kidney bean extract makes novel small-format products feasible — lozenges, oral dissolving tablets and sublingual-style melts — where every milligram of formula space is precious.

Standardized to 20,000 AAIU/g from non-GMO Yunnan certified bases, this concentrated grade fits meaningful marker loads into small, fast-dissolving formats with minimal filler.

It suits lozenges, melts and confection-adjacent formats; we provide free samples, novel-format feasibility support, custom specs and OEM/ODM development.

Why Novel Formats Need Concentration

Small formats have tiny weight budgets. A 500 mg lozenge cannot carry 500 mg of a standard extract plus base materials. P40C's 0.15 g–0.6 g load makes the format physically possible:

• Marker delivery in small lozenge sizes.
• Fast-dissolving textures without chalky residue.
• Room for flavor and sweetness in every unit.
• Format differentiation in a crowded market.

Feasibility Before Investment

We evaluate dissolution, taste and processing fit before you commit tooling — saving the expensive trial-and-error that kills novel launches.

Innovation Pipeline Support

From concept sketches to production trials, our team helps you move novel formats forward. For custom development, explore our custom plant extract formulation service; for pressed candy references, view our white kidney bean capsules; for standard-grade flexibility, check our KK‑Type white kidney beans extract.

FAQ

Q1: Can P40C work in lozenges?

A: Yes. Its concentration fits full marker loads into small lozenge sizes with room for base materials.

Q2: What novel formats are feasible?

A: Lozenges, oral dissolving tablets, melts and confection-adjacent formats.

Q3: Do you assess feasibility before production?

A: Yes, including dissolution, taste and processing-fit evaluation before tooling commitment.